Oligometastatic prostatic cancer recurrence: role of salvage lymph node dissection (sLND) and radiation therapy-stereotactic body radiation therapy (RT-SBRT)

Mohamed E. Ahmed, Ryan M. Phillips, Vidit Sharma, Brian J Davis, R. Jeffrey Karnes

Research output: Contribution to journalArticlepeer-review

Abstract

PURPOSE OF REVIEW: Metastases directed therapy (MDT) is an increasingly utilized modality in patients with oligometastatic prostate cancer (OMPC) recurrence. The purpose of our review is to discuss the recent literature on the safety and oncologic outcomes of this treatment approach. RECENT FINDINGS: Metastases directed therapy, in particular, stereotactic body radiation therapy (SBRT) and salvage lymph node dissection (sLND), has shown promising efficacy in patients with OMPC. Many case series report favorable outcomes with MDT as compared to hormonal deprivation therapy alone or surveillance. Of the few case series investigating the use of MDT as part of a multimodality approach in castrate-resistant OMPC, more favorable outcomes in comparison to the use of systemic treatment alone are reported. SUMMARY: With the recent advances in imaging techniques, particularly molecular imaging, management of OMPC has progressed rapidly in the last few years. The feasibility and benefits of MDT in OMPC have been demonstrated in prospective and retrospective series. Further prospective studies investigating the role of MDT to define optimal patient subgroups and management strategies are warranted.

Original languageEnglish (US)
Pages (from-to)199-205
Number of pages7
JournalCurrent Opinion in Urology
Volume31
Issue number3
DOIs
StatePublished - May 1 2021

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Oligometastatic prostatic cancer recurrence: role of salvage lymph node dissection (sLND) and radiation therapy-stereotactic body radiation therapy (RT-SBRT)'. Together they form a unique fingerprint.

Cite this